250 related articles for article (PubMed ID: 11194594)
1. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
[TBL] [Abstract][Full Text] [Related]
3. [DDD versus DDDR pacemaker stimulation: comparison of cardiopulmonary performance, incidence of atrial arrhythmias and quality of life].
Epperlein S; Kreft A; Siegert V; Liebrich A; Himmrich E; Treese N
Z Kardiol; 1996 Apr; 85(4):226-36. PubMed ID: 8693765
[TBL] [Abstract][Full Text] [Related]
4. Improved cardiac function and quality of life following upgrade to dual chamber pacing after long-term ventricular stimulation.
Höijer CJ; Brandt J; Willenheimer R; Juul-Möller S; Boström PA
Eur Heart J; 2002 Mar; 23(6):490-7. PubMed ID: 11863352
[TBL] [Abstract][Full Text] [Related]
5. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
[TBL] [Abstract][Full Text] [Related]
7. Long-term haemodynamic and antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence.
Santini M; Ricci R; Puglisi A; Mangiameli S; Proclemer A; Menozzi C; De Fabrizio G; Leoni G; Lisi F; De Seta F
G Ital Cardiol; 1997 Sep; 27(9):892-900. PubMed ID: 9378194
[TBL] [Abstract][Full Text] [Related]
8. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation.
de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP
Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study.
Bellocci F; Spampinato A; Ricci R; Puglisi A; Capucci A; Dini P; Boriani G; Botto G; Curnis A; Moracchini PV; Nicotra G; Lisi F; Nigro P
Europace; 1999 Oct; 1(4):220-5. PubMed ID: 11220558
[TBL] [Abstract][Full Text] [Related]
10. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
[TBL] [Abstract][Full Text] [Related]
11. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia.
Padeletti L; Pieragnoli P; Ciapetti C; Colella A; Musilli N; Porciani MC; Ricci R; Pignalberi C; Santini M; Puglisi A; Azzolini P; Spampinato A; Martelli M; Capucci A; Boriani G; Botto G; Proclemer A
Am Heart J; 2001 Dec; 142(6):1047-55. PubMed ID: 11717611
[TBL] [Abstract][Full Text] [Related]
12. Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation.
Pürerfellner H; Urban L; de Weerd G; Ruiter J; Brandt J; Havlicek A; Hügl B; Widdershoven J; Kornet L; Kessels R
Europace; 2009 Jan; 11(1):62-9. PubMed ID: 19008238
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360
[TBL] [Abstract][Full Text] [Related]
14. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group.
Puglisi A; Favale S; Scipione P; Melissano D; Pavia L; Ascani F; Elia M; Scaccia A; Sagone A; Castaldi B; Musacchio E; Botto GL;
Pacing Clin Electrophysiol; 2008 Nov; 31(11):1443-55. PubMed ID: 18950302
[TBL] [Abstract][Full Text] [Related]
15. Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment.
Ward KJ; Willett JE; Bucknall C; Gill JS; Kamalvand K
Europace; 2001 Apr; 3(2):108-14. PubMed ID: 11333047
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
[TBL] [Abstract][Full Text] [Related]
17. Ventricular pacing vs dual chamber pacing in patients with persistent atrial fibrillation after atrioventricular node ablation: open randomized study.
Petrac D; Radić B; Radeljić V; Hamel D; Filipović J
Croat Med J; 2005 Dec; 46(6):922-8. PubMed ID: 16342345
[TBL] [Abstract][Full Text] [Related]
18. Septal atrial pacing for the prevention of atrial fibrillation.
Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
[TBL] [Abstract][Full Text] [Related]
19. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunction.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Glotzer TV; Silverman R; Yee R; Lee KL; Lamas GA;
J Cardiovasc Electrophysiol; 2004 Feb; 15(2):153-60. PubMed ID: 15028043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
